Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice

Journal of Experimental Medicine

Volumn 184, Issue 6, 1996, Pages 2271-2278

  Wolf, Susan D ^a   Dittel, Bonnie N ^a   Hardardottir, Fridrika ^a   Janeway Jr , Charles A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; DISEASE SEVERITY; EXPERIMENTAL MODEL; IMMUNE DEFICIENCY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CYTOKINES; DNA PRIMERS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; IMMUNOGLOBULIN MU-CHAINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE DELETION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 0030456897     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.6.2271     Document Type: Article

References (53)

1. Martin, R., and H.F. McFarland. 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32:121-182.
2. Ben-Nun, A., H. Wekerle, and I.R. Cohen. 1981. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:195-199.
3. Zamil, S.S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579-621.
4. Fritz, R.B., M.J. Skeen, C.H. Jen-Chou, M. Garcia, and I.K. Egorov. 1985. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J. Immunol. 134:2328-2332.
5. Martin, R., H.F. McFarland, and D.E. McFarlin. 1992. Immunology of demyelinating diseases. Annu. Rev. Immunol. 10: 153-187.
6. Willenborg, D.O., and S.J. Prowse. 1983. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J Neuroimmunol. 5:99-109.
7. Willenborg, D.O., P. Sjollema, and G. Danta. 1986. Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis. J. Neuroimmunol. 11:93-103.
8. Myers, K.J., J. Sprent, J.P. Dougherty, and Y. Ron. 1992. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 41:1-8.
9. Kitamura, D., and K. Rajewsky. 1992. Targeted disruption of μ chain membrane exon causes loss of heavy-chain allelic exclusion. Nature (Lond.). 356:154-156.
10. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature (Lond.). 350:423-426.
11. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181: 1569-1574.
12. Epstein, M.M., F. DiRosa, D. Jankovic, A. Sher, and P. Matzinger. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182:915-922.
13. Urban, J.L., V. Kumar, D.H. Kono, C. Gomez, S.J. Horvath, J. Clayton, D.G. Ando, E.E. Sercarz, and L. Hood. 1988. Restricted use of the T cell receptor V genes in murine autoimmune encephalomyelitis raises the possibilities for antibody therapy. Cell. 54:577-592.
14. Acha-Orbea, H., D.J. Mitchell, L. Timmermann, D.C. Wraith, G.S. Tausch, M.K. Waldor, S.S. Zamvill, H.O. McDevitt, and L. Steinman. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 54:263-273.
15. + T cells to protein antigens in vivo. J. Immunol. 155:3734-3741.
16. + T cell activation and tolerance induction in B cell knockout mice. J. Exp. Med. 183:1339-1344.
17. Sunshine, G.H., B.L. Jimmo, C. Ianelli, and L. Jarvis. 1991. Strong priming of T cells adoptively transferred into scid mice J. Exp. Med. 174:1653-1656.
18. Metlay, J.P., E. Puré, and R.M. Steinman. 1989. Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction. J. Exp. Med. 169:239-254.
19. Inaba, K., and R.M. Steinman. 1984. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J. Exp. Med. 160:1717-1735.
20. Inaba, K., J.P. Metlay, M.T. Crowley, and R.M. Steinman. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631-640.
21. Sornasse, T., V. Flamand, G. De Becker, H. Bazin, F. Tielemans, K. Thielmans, J. Urbain, O. Leo, and M. Moser. 1992. Antigen-pulsed dendritic cells can efficiently induce antibody response in vivo. J. Exp. Med. 175:15-21.
22. Guery, J.C., F. Ria, and L. Adorini. 1996. Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J. Exp. Med. 183:751-757.
23. Ronchese, F., and B. Hausmann. 1993. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J. Exp. Med. 177:679-690.
24. Morris, S.C., A. Lees, and F.D. Finkelman. 1994. In vivo activation of naive T cells by antigen-presenting B cells. J. Immunol. 152:3777-3785.
25. Eynon, E.E., and D.C. Parker. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:131-138.
26. Lassila, O., O. Vainio, and P. Matzinger. 1988. Can B cells turn on virgin T cells? Nature (Lond.). 334:253-255.
27. Fuchs, E.F., and P. Matzinger. 1992. B cells turn off virgin but not memory T cell:. Science (Wash. DC). 258:1156-1159.
28. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature (Lond.). 314:537-539.
29. Metlay, J.P., E. Puré, and R.M. Steinman. 1989. Control of the immune response at the level of antigen-presenting cells: a comparison of the function of dendritic and B lymphocytes. Adv. Immunol. 47:45-116.
30. Cassell, D.J., and R.H. Schwartz. 1994. A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J. Exp. Med. 180:1829-1840.
31. Krieger, J.I., S.F. Graminer, H.M. Grey, and R.W. Chesnut. 1985. Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses. J. Immunol. 135:2937-2945.
32. Hawrylowicz, C.M., and E.R. Unanue. 1988. Regulation of antigen-presentation-I. INF-γ induces antigen-presenting properties on B cells. J. Immunol. 141:4083-4088.
33. Liu, Y., and C.A. Janeway, Jr. 1991. Microbial induction of costimulatory activity for CD4 T-cell growth. Int. Immunol. 3:323-332.
34. Lin, R.H., M.J. Mamula, J.A. Hardin, and C.A. Janeway, Jr. 1991. Induction of autoreactive B cells allows priming of autoreactive T cells. J. Exp. Med. 173:1433-1439.
35. Croft, M., and S.L. Swain. 1995. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine Il-4 to drive differentiation to secretion of T helper 2-type cytokines. J. Immunol. 154:4269-4282.
36. Kurt-Jones, E.A., D. Liano, K.A. Hayglass, B. Benacerraf, M.S. Sy, and A.K. Abbas. 1988. The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J. Immunol. 140:3773-3778.
37. Finkelman, F.D. 1995. Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease. J. Exp. Med. 182:279-282.
38. Racke, M.K., A. Bonomo, D.E. Scott, B. Cannella, A. Levine, C.S. Raine, E.M. Shevach, and M. Röcken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961-1966.
39. Baron, J.L., J.A. Madri, N.H. Ruddle, G. Hashim, and C.A. Janeway, Jr. 1993. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57-68.
40. Röcken, M., J. Urban, and E.M. Shevach. 1994. Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo. J. Exp. Med. 179:1885-1893.
41. Fiorentino, D.F., M.W. Bond, and T.R. Mosmann. 1989. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2095.
42. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589-600.
43. Stockinger, B., T. Zal, A. Zal, and D. Gray. 1996. B cells solicit their own help from T cells. J. Exp. Med. 183:891-899.
44. Gajewski, T.F., S.R. Schell, G. Nau, and F.W. Fitch. 1989. Regulation of T-cell activation: differences among T-cell subsets. Immunol. Rev. 111:79-110.
45. Saoudi, A., S. Simmonds, I. Huitinga, and D. Mason. 1995. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J. Exp. Med. 182:335-344.
46. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M.N. Woodroofe, M.L. Cuzner, and D.A. Hafler. 1995. Expression of costimulatory molecule B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985-1996.
47. Ron, Y., P. De Baetselier, J. Gordon, M. Feldman, and S. Segal. 1981. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. Eur. J. Immunol. 11: 964-968.
48. Sacks, D.L., P.A. Scott, R. Asofsky, and F.A. Sher. 1984. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J. Immunol. 132: 2072-2077.
49. Hayglass, K.T., S.J. Naides, C.F. Scott, Jr., B. Benacerraf, and M.S. Sy. 1986. T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cell in vivo. J. Immunol. 136:823-829.
50. Janeway, C.A, Jr., J. Ron, and M.E. Katz. 1987. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J. Immunol. 138:1051-1055.
51. + T cell subsets to Plasmodium chabaudi chaboudi in B cell-deficient mice. Int. Immunol. 5:1343-1348.
52. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:707-718.
53. + T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909-916.